Cataract & IOLReview
Premium IOLs: look beyond the visual acuity chart
A new review examines patient-reported outcomes after multifocal and extended depth-of-focus IOL implantation, including visual quality and spectacle independence.
THE DAILY SELECTION17 Sept 2026
Today in ophthalmology.
Five developments. The evidence behind them.
Today’s top five
8 minRetinaTrial Update
Geographic atrophy: the SIGLEC record is updated
ClinicalTrials.gov lists the phase II AVD-104 study as completed. The registry record was updated on 16 September; no results are posted in the retrieved record.
Surgical technologyCompany Announcement
ZEISS expands its cataract and digital workflow portfolio
At ESCRS 2026, ZEISS announced a toric IOL, a cataract configuration of EVA NEXUS and updates to digital surgical planning.
CorneaObservational Study
Ten years after keratoplasty: read the differences carefully
A retrospective Hong Kong cohort followed 74 eyes after DSEK/DSAEK or penetrating keratoplasty. The study reports long-term graft survival and visual outcomes.
Device regulationRegulatory Update
EUDAMED: four modules are now mandatory
From 28 May 2026, mandatory use applies to actor registration, UDI/device registration, notified bodies and certificates, and market surveillance.
JOURNAL WATCH
Evidence
Observational StudyGlaucoma
ELIOS with phaco: 24-month pivotal study published
A prospective multicentre, non-randomised device trial reports 24-month outcomes in 318 patients with glaucoma and cataract.
RCTCataract & IOL
A new OVD study: separate randomised and single-arm data
The Minivisc Plus study includes 163 eyes, but the randomised comparative phase includes 54. The remaining phase is not a randomised comparison.
Tech watch
Study ProtocolDigital ophthalmology
MI-SIGHT 2: testing a technology-based screening pathway
A published protocol describes a pragmatic randomised comparison of a telemedicine-based eye disease screening pathway with usual optometric care.
On your reference shelf
Official guideline
European Glaucoma Society
Sixth edition. A versioned starting point for your glaucoma reference library.
Source dossier OcuRadar PREVIEW
Your specialty. Your signals.
Follow the diseases, therapies and technologies that matter to you. Build your first watchlist.
Explore OcuRadarGeographic atrophyFollow
FaricimabFollow
ZEISSFollow
SLTFollow